Royalty Pharma declares $0.235 per share dividend for third quarter 2026

GlobeNewswire··Read original
1▲1 ▼0Impact / 5
Summary · why it matters

Royalty Pharma's board of directors has approved a third-quarter 2026 dividend of $0.235 per Class A ordinary share. The dividend will be paid on September 10, 2026, to shareholders of record as of the close of business on August 14, 2026.

Impact on assets 1

Biotech & Genomic Medicine▲ · 1 stocks
Royalty Pharma Plc
RPRX
▲ PositiveCapitalrelevance

Company declares a quarterly dividend, a direct financial event returning capital to shareholders.